Education
About Us
Working with TipRanks
Follow Us
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989)
:9989
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 5.28B | ¥ 5.45B | ¥ 7.16B | ¥ 6.37B | ¥ 5.33B |
| Gross Profit | ¥ 1.76B | ¥ 1.80B | ¥ 2.33B | ¥ 2.03B | ¥ 2.09B |
| Operating Income | ¥ 741.31M | ¥ -238.11M | ¥ 1.14B | ¥ 773.20M | ¥ 1.33B |
| EBITDA | ¥ 1.20B | - | ¥ 1.37B | ¥ 726.64M | ¥ 1.88B |
| Net Income | ¥ 646.74M | - | ¥ 727.43M | ¥ 240.79M | ¥ 1.02B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 2.56B | ¥ 2.27B | ¥ 3.45B | ¥ 3.93B | ¥ 3.54B |
| Total Assets | ¥ 17.34B | ¥ 19.20B | ¥ 20.81B | ¥ 19.11B | ¥ 19.03B |
| Total Debt | ¥ 2.98B | ¥ 3.78B | ¥ 6.46B | ¥ 5.65B | ¥ 5.65B |
| Net Debt | ¥ 1.29B | ¥ 1.93B | ¥ 4.33B | ¥ 2.71B | ¥ 2.93B |
| Total Liabilities | ¥ 5.14B | ¥ 7.22B | ¥ 8.41B | ¥ 7.58B | ¥ 7.34B |
| Stockholders' Equity | ¥ 12.15B | ¥ 11.91B | ¥ 12.31B | ¥ 11.41B | ¥ 11.57B |
| Cash Flow | |||||
| Free Cash Flow | ¥ 1.99B | ¥ -46.66M | ¥ -979.03M | ¥ -200.49M | ¥ -175.21M |
| Operating Cash Flow | ¥ 2.19B | ¥ 398.22M | ¥ -756.61M | ¥ -6.63M | ¥ 37.28M |
| Investing Cash Flow | ¥ -415.05M | ¥ 1.22B | ¥ 249.84M | ¥ 719.93M | ¥ -2.17B |
| Financing Cash Flow | ¥ -2.14B | ¥ -1.21B | ¥ 329.56M | ¥ -501.08M | ¥ 2.51B |